SB 1251 – Arizona

Status: In Process
Year Introduced: 2024

This bill amends the Arizona Revised Statutes title 32, chapter 18, article 3 by adding a new section. The main focus of the bill is the regulation of prescription drugs under the 340B Drug Pricing Program. This federal government program requires drug manufacturers to provide outpatient drugs at significantly reduced prices to healthcare organizations that care for underserved populations. The bill prohibits any manufacturer, repackager, third-party logistics provider, or wholesale distributor from restricting or limiting the acquisition of a 340B drug by a recognized 340B covered entity. It also bars these parties from requiring a 340B covered entity to submit any claims or usage data as a condition for accessing these reduced prices, unless such sharing is required by the US Department of Health and Human Services. If any violations of these prescriptions occur, disciplinary actions may be enforced by the Arizona State Board of Pharmacy. The bill does not provide for private legal action against violating entities.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found